Saturday 17 October 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue grew 27.2%, EPS grew 9.88%, free cash flow grew 6.50% and total debt rose 1.12%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
6.73
0.56
−7.68%
Follow SOPH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 2 | 2 |
+8 more TTM periods Free account |
| (101.22%) | (123.28%) | (110.00%) | (86.09%) | ||
| (43.02%) | (53.30%) | (49.63%) | (43.97%) | ||
ROIC |
(196.45%) | (160.25%) | (180.23%) | (163.73%) | |
Return on Tangible Assets |
(88.77%) | (149.02%) | (145.71%) | (104.91%) | |
Average Days of Receivables |
59.78 | 64.35 | 70.86 | 42.10 | |
Free Cash Flow per Share |
(0.56) | (0.59) | (0.54) | (0.58) | |
Free Cash Flow |
(41.21) | (41.81) | (36.63) | (39.03) | |
Capital Expenditures |
(1.47) | (1.55) | (0.74) | (0.59) | |
| Other line items | |||||
Cash ROIC |
(17.26%) | (26.31%) | (22.18%) | (20.56%) | |
Accounts Receivable Turnover |
7.30 | 6.49 | 6.89 | 8.05 | |
Accounts Payable Turnover |
2.93 | 3.08 | 3.55 | 3.99 | |
Inventory Turnover |
4.32 | 4.38 | 4.12 | 3.62 | |
Average Days of Payables |
151.09 | 174.08 | 129.81 | 92.84 | |
Days of Inventory on Hand |
89.91 | 97.37 | 92.01 | 102.40 | |
Tax Rate |
0.01 | 0.02 | 0.02 | 0.03 | |
Research and Development Expense of Revenue |
40.38% | 42.57% | 44.28% | 47.51% | |
Selling, General and Administrative Expense of Revenue |
111.61% | 113.47% | 114.77% | 115.35% | |
Share Based Compensation of Revenue |
18.36% | 19.32% | 20.97% | 23.76% | |
Interest Coverage |
(11.13) | (12.97) | (15.57) | (19.61) | |
Operating CF/Net income |
0.49 | 0.50 | 0.45 | 0.51 | |
Depreciation/Fixed assets |
2.15 | 1.96 | 1.68 | 1.91 | |
Capex/Depreciation |
(0.14) | (0.15) | (0.08) | (0.06) | |
Revenue per Share |
1.17 | 1.14 | 1.14 | 1.08 | |
Operating CF per Share |
(0.54) | (0.57) | (0.53) | (0.57) | |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates